無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のDPP-4阻害薬産業における成長動向と競合分析:2018年〜2025年

Global DPP IV Inhibitors (DPP-4 Inhibitors) Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

発行 QYResearch 商品コード 684948
出版日 ページ情報 英文 115 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=113.52円で換算しております。
Back to Top
世界のDPP-4阻害薬産業における成長動向と競合分析:2018年〜2025年 Global DPP IV Inhibitors (DPP-4 Inhibitors) Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
出版日: 2018年08月27日 ページ情報: 英文 115 Pages
概要

当レポートでは、世界のDPP-4阻害薬産業について調査分析し、市場規模 (実績と予測) 、地域別の主要データのほか、世界市場の状況、競合情勢、市場シェア、成長率、将来動向、市場促進要因、機会と課題、販売チャネルなど、体系的な情報を提供しています。

第1章 レポート概要

第2章 世界の成長動向

  • 市場規模
  • 成長率:地域別
  • 産業動向

第3章 市場シェア:メーカー別

  • 売上:メーカー別
  • 収益:メーカー別
  • 価格:メーカー別
  • 主要メーカーの工場分布と地域
  • 主要メーカーの市場参入日
  • 主要メーカーの提供製品
  • M&A、事業拡大計画

第4章 市場規模:タイプ別

  • 各タイプの売上と収益
  • 売上の市場シェア:タイプ別
  • 収益の市場シェア:タイプ別
  • 価格:タイプ別

第5章 市場規模:用途別

  • 概要
  • 売上:用途別

第6章 北米

  • 内訳データ:企業別
  • 内訳データ:タイプ別
  • 内訳データ:用途別
  • 内訳データ:国別

第7章 欧州

  • 内訳データ:企業別
  • 内訳データ:タイプ別
  • 内訳データ:用途別
  • 内訳データ:国別

第8章 アジア太平洋地域

  • 内訳データ:企業別
  • 内訳データ:タイプ別
  • 内訳データ:用途別
  • 内訳データ:国別

第9章 中南米

  • 内訳データ:企業別
  • 内訳データ:タイプ別
  • 内訳データ:用途別
  • 内訳データ:国別

第10章 中東・アフリカ

  • 内訳データ:企業別
  • 内訳データ:タイプ別
  • 内訳データ:用途別
  • 内訳データ:国別

第11章 企業プロファイル

  • AstraZeneca
  • Boehringer
  • Eli Lilly
  • Merck
  • 田辺三菱製薬
  • Novartis
  • 武田薬品工業

第12章 バリューチェーン・販売チャネル分析

  • バリューチェーン分析
  • 販売チャネル分析
  • カスタマー

第13章 市場予測

  • 売上・収益予測
  • 売上予測:タイプ別
  • 売上予測:用途別
  • 予測:地域別
  • 北米
  • 欧州
  • アジア太平洋地域
  • 中南米
  • 中東・アフリカ

第14章 調査結果と結論

第15章 付録

図表

List of Tables and Figures

  • Figure DPP IV Inhibitors (DPP-4 Inhibitors) Product Picture
  • Table DPP IV Inhibitors (DPP-4 Inhibitors) Key Market Segments
  • Table Major Manufacturers DPP IV Inhibitors (DPP-4 Inhibitors) Covered in This Report
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Shar by Type 2013-2025
  • Figure Sitagliptin Figures
  • Table Major Manufacturers of Sitagliptin
  • Figure Vildagliptin Figures
  • Table Major Manufacturers of Vildagliptin
  • Figure Saxagliptin Figures
  • Table Major Manufacturers of Saxagliptin
  • Figure Linagliptin Figures
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application 2018-2025 (K Units)
  • Figure DPP IV Inhibitors (DPP-4 Inhibitors) Report Years Considered
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size 2013-2025 (Million US$)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales 2013-2018 (K Units)
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size by Regions 2013-2018 (K Units) & (Million US$)
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Regions 2013-2018 (K Units)
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Regions 2013-2018
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Regions 2013-2018
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Regions in 2018
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Regions 2013-2018 (Million US$)
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Regions 2013-2018
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Regions 2013-2018
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Manufacturers (2013-2018) (K Units)
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Share by Manufacturers (2013-2018)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Share by Manufacturers in 2018
  • Table DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Manufacturers (2013-2018) (Million USD)
  • Table DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Share by Manufacturers (2013-2018)
  • Figure DPP IV Inhibitors (DPP-4 Inhibitors) Value Share by Manufacturers in 2018
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers DPP IV Inhibitors (DPP-4 Inhibitors) Price (2013-2018) (USD/Unit)
  • Table Key Manufacturers DPP IV Inhibitors (DPP-4 Inhibitors) Plants/Factories Distribution
  • Table Key Manufacturers DPP IV Inhibitors (DPP-4 Inhibitors) Area Served
  • Table Date of Key Manufacturers Enter into DPP IV Inhibitors (DPP-4 Inhibitors) Market
  • Table Key Manufacturers DPP IV Inhibitors (DPP-4 Inhibitors) Product Type
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Sitagliptin Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global Vildagliptin Sales and Revenue (2013-2018) (K Units) & (Million US$)
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Type (2013-2018) (K Units)
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Share by Type (2013-2018)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type (2013-2018)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type in 2017
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Type (2013-2018) (Million US$)
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Share by Type (2013-2018)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Type (2013-2018)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Type in 2017
  • Table DPP IV Inhibitors (DPP-4 Inhibitors) Price by Type 2013-2018 (USD/Unit)
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application (2013-2018) (K Units)
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Share by Application (2013-2018)
  • Figure Global Sales DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application (2013-2018)
  • Figure Global Sales DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application in 2017
  • Figure North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate 2013-2018 (K Units)
  • Figure North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate 2013-2018 (Million US$)
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Company (2013-2018) (K Units)
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Company (2013-2018)
  • Figure North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Company in 2018
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Type (2013-2018) (K Units)
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type (2013-2018)
  • Figure North America DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Type in 2018
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application (2013-2018) (K Units)
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application (2013-2018)
  • Figure North America DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application in 2018
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Countries (2013-2018) (K Units)
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Countries (2013-2018)
  • Figure 2017 North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Countries
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Countries (2013-2018) (Million US$)
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Countries (2013-2018)
  • Figure 2017 North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Countries
  • Figure United States DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Canada DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Mexico DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate 2013-2018 (K Units)
  • Figure Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate 2013-2018 (Million US$)
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Company (2013-2018) (K Units)
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Company (2013-2018)
  • Figure Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Company in 2018
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Type (2013-2018) (K Units)
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type (2013-2018)
  • Figure 2017 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Type
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application (2013-2018) (K Units)
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application (2013-2018)
  • Figure 2017 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Countries (2013-2018) (K Units)
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Countries (2013-2018)
  • Figure 2017 Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Countries
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Countries (2013-2018) (Million US$)
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Countries (2013-2018)
  • Figure Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Countries in 2018
  • Figure Germany DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure France DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure UK DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Italy DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Russia DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate 2013-2018 (K Units)
  • Figure Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate 2013-2018 (Million US$)
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Company (2013-2018) (K Units)
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Company (2013-2018)
  • Figure Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Company in 2018
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Type (2013-2018) (K Units)
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type (2013-2018)
  • Figure Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Type in 2018
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application (2013-2018) (K Units)
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application (2013-2018)
  • Figure Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application in 2018
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Countries (2013-2018) (K Units)
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Countries
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Countries (2013-2018) (Million US$)
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Countries
  • Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Japan DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Japan DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Korea DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Korea DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (Million US$)
  • Figure India DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure India DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Australia DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Australia DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Indonesia DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Indonesia DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Malaysia DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Malaysia DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Philippines DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Philippines DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Thailand DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Thailand DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Vietnam DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Vietnam DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate 2013-2018 (K Units)
  • Figure Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate 2013-2018 (Million US$)
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Company (2013-2018) (K Units)
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Company (2013-2018)
  • Figure Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Company in 2018
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Type (2013-2018) (K Units)
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type (2013-2018)
  • Figure Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Type in 2018
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application (2013-2018) (K Units)
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application (2013-2018)
  • Figure Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application in 2018
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Countries (2013-2018) (K Units)
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Countries (2013-2018)
  • Figure Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Countries in 2018
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Countries (2013-2018) (Million US$)
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Countries (2013-2018)
  • Figure Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Countries in 2018
  • Figure Brazil DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Brazil DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (K Units)
  • Figure Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate 2013-2018 (K Units)
  • Figure Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate 2013-2018 (Million US$)
  • Table Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Type (2013-2018) (K Units)
  • Table Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type (2013-2018)
  • Figure 2017 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Type
  • Table Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application (2013-2018) (K Units)
  • Table Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Application (2013-2018)
  • Figure 2017 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application
  • Table Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Countries (2013-2018) (K Units)
  • Table Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Countries
  • Table Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Countries (2013-2018) (Million US$)
  • Table Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Countries
  • Figure GCC Countries DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure GCC Countries DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (K Units)
  • Figure Egypt DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure Egypt DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (K Units)
  • Figure South Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018) (K Units)
  • Figure South Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Growth Rate (2013-2018) (K Units)
  • Table AstraZeneca Company Details
  • Table AstraZeneca Description and Business Overview
  • Table AstraZeneca DPP IV Inhibitors (DPP-4 Inhibitors) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table AstraZeneca DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018)
  • Table AstraZeneca DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share in Global Market
  • Table AstraZeneca Recent Development
  • Table Boehringer Company Details
  • Table Boehringer Description and Business Overview
  • Table Boehringer DPP IV Inhibitors (DPP-4 Inhibitors) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Boehringer DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018)
  • Table Boehringer DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share in Global Market
  • Table Boehringer Recent Development
  • Table Eli Lilly Company Details
  • Table Eli Lilly Description and Business Overview
  • Table Eli Lilly DPP IV Inhibitors (DPP-4 Inhibitors) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Eli Lilly DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018)
  • Table Eli Lilly DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share in Global Market
  • Table Eli Lilly Recent Development
  • Table Merck Company Details
  • Table Merck Description and Business Overview
  • Table Merck DPP IV Inhibitors (DPP-4 Inhibitors) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Merck DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018)
  • Table Merck DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share in Global Market
  • Table Merck Recent Development
  • Table Mitsubishi Tanabe Pharma Company Details
  • Table Mitsubishi Tanabe Pharma Description and Business Overview
  • Table Mitsubishi Tanabe Pharma DPP IV Inhibitors (DPP-4 Inhibitors) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Mitsubishi Tanabe Pharma DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018)
  • Table Mitsubishi Tanabe Pharma DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share in Global Market
  • Table Mitsubishi Tanabe Pharma Recent Development
  • Table Novartis Company Details
  • Table Novartis Description and Business Overview
  • Table Novartis DPP IV Inhibitors (DPP-4 Inhibitors) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Table Novartis DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2013-2018)
  • Table Novartis DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share in Global Market
  • Table Novartis Recent Development
  • Table Takeda Company Details
  • Table Takeda Description and Business Overview
  • Table Takeda DPP IV Inhibitors (DPP-4 Inhibitors) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
  • Figure DPP IV Inhibitors (DPP-4 Inhibitors) Value Chain
  • Table DPP IV Inhibitors (DPP-4 Inhibitors) Distributors List
  • Table DPP IV Inhibitors (DPP-4 Inhibitors) Customers List
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units) & (Million US$)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast 2018-2025 (Million US$)
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Type 2018-2025 (K Units)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share Forecast by Type 2018-2025
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Application 2018-2025 (K Units)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share Forecast by Application 2018-2025
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Regions 2018-2025 (K Units)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share Forecast by Regions 2018-2025
  • Table Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share Forecast by Regions 2018-2025
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Countries 2018-2025 (K Units)
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share Forecast by Countries 2018-2025
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share Forecast by Countries 2018-2025
  • Figure United States DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure Canada DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure MexicoDPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Countries 2018-2025 (K Units)
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share Forecast by Countries 2018-2025
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share Forecast by Countries 2018-2025
  • Figure Germany DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure France DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure UK DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure Italy DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure Russia DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Countries 2018-2025 (K Units)
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share Forecast by Countries 2018-2025
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share Forecast by Countries 2018-2025
  • Figure China DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure Japan DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure Korea DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure India DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure Australia DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure Indonesia DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure Thailand DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure Malaysia DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure Philippines DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Figure Vietnam DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Countries 2018-2025 (K Units)
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share Forecast by Countries 2018-2025
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share Forecast by Countries 2018-2025
  • Figure Brazil DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast 2018-2025 (K Units)
  • Table Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Regions 2018-2025 (K Units)
  • Table Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share Forecast by Regions 2018-2025
  • Table Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Regions 2018-2025 (Million US$)
  • Table Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share Forecast by Regions 2018-2025
  • Figure GCC Countries DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2016-2025) (K Units)
  • Figure Egypt DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2016-2025) (K Units)
  • Figure South Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Growth Rate (2016-2025) (K Units)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
目次

This study researches the market size of DPP IV Inhibitors (DPP-4 Inhibitors), presents the global DPP IV Inhibitors (DPP-4 Inhibitors) sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

This report focuses on the key data information of DPP IV Inhibitors (DPP-4 Inhibitors) in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of DPP IV Inhibitors (DPP-4 Inhibitors) for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

DPP IV inhibitors are a class of hypoglycemic agents that block the enzyme named dipeptidyl peptidase IV. Dipeptidyl peptidase IV enzyme break down the proteins that are responsible for stimulating the insulin producing cells that slows down gastric secretion. Proteins can activate the release of insulin and can control the blood sugar level if DPP IV is inhibited in our body.

Geographically, North America and Europe dominates the global market for DPP IV inhibitors due to high prevalence rate and rising awareness among people about the DPP IV inhibitors. Asia-Pacific is considered as a fastest growing market due to increasing obese population.

In 2018, the global DPP IV Inhibitors (DPP-4 Inhibitors) market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for DPP IV Inhibitors (DPP-4 Inhibitors).

This report includes the following manufacturers; we can also add the other companies as you want.

  • AstraZeneca
  • Boehringer
  • Eli Lilly
  • Merck
  • Mitsubishi Tanabe Pharma
  • Novartis
  • Takeda

Market Segment by Product Type

  • Sitagliptin
  • Vildagliptin
  • Saxagliptin
  • Linagliptin
  • Others

Market Segment by Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Market size split by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global DPP IV Inhibitors (DPP-4 Inhibitors) status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key DPP IV Inhibitors (DPP-4 Inhibitors) manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of DPP IV Inhibitors (DPP-4 Inhibitors) are as follows:

  • History Year: 2013-2018
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

Table of Contents

1. Report Overview

  • 1.1. Research Scope
  • 1.2. Major Manufacturers Covered in This Report
  • 1.3. Market Segment by Type
    • 1.3.1. Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size Growth Rate by Type
    • 1.3.2. Sitagliptin
    • 1.3.3. Vildagliptin
  • 1.4. Market Segment by Application
    • 1.4.1. Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Share by Application (2018-2025)
  • 1.5. Study Objectives
  • 1.6. Years Considered

2. Global Growth Trends

  • 2.1. Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Size
    • 2.1.1. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue 2013-2025
    • 2.1.2. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales 2013-2025
  • 2.2. DPP IV Inhibitors (DPP-4 Inhibitors) Growth Rate by Regions
    • 2.2.1. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Regions 2013-2018
    • 2.2.2. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Regions 2013-2018
  • 2.3. Industry Trends
    • 2.3.1. Market Top Trends
    • 2.3.2. Market Drivers

3. Market Share by Manufacturers

  • 3.1. DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Manufacturers
    • 3.1.1. DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Manufacturers 2013-2018
    • 3.1.2. DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Manufacturers 2013-2018
  • 3.2. Revenue by Manufacturers
    • 3.2.1. DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Manufacturers (2013-2018)
    • 3.2.2. DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Share by Manufacturers (2013-2018)
    • 3.2.3. Global DPP IV Inhibitors (DPP-4 Inhibitors) Market Concentration Ratio (CR5. and HHI)
  • 3.3. DPP IV Inhibitors (DPP-4 Inhibitors) Price by Manufacturers
  • 3.4. Key Manufacturers DPP IV Inhibitors (DPP-4 Inhibitors) Plants/Factories Distribution and Area Served
  • 3.5. Date of Key Manufacturers Enter into DPP IV Inhibitors (DPP-4 Inhibitors) Market
  • 3.6. Key Manufacturers DPP IV Inhibitors (DPP-4 Inhibitors) Product Offered
  • 3.7. Mergers & Acquisitions, Expansion Plans

4. Market Size by Type

  • 4.1. Sales and Revenue for Each Type
    • 4.1.1. Sitagliptin Sales and Revenue (2013-2018)
    • 4.1.2. Vildagliptin Sales and Revenue (2013-2018)
  • 4.2. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Market Share by Type
  • 4.3. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Market Share by Type
  • 4.4. DPP IV Inhibitors (DPP-4 Inhibitors) Price by Type

5. Market Size by Application

  • 5.1. Overview
  • 5.2. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Application

6. North America

  • 6.1. North America DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Company
  • 6.2. North America DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Type
  • 6.3. North America DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Application
  • 6.4. North America DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Countries
    • 6.4.1. North America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Countries
    • 6.4.2. North America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Countries
    • 6.4.3. United States
    • 6.4.4. Canada
    • 6.4.5. Mexico

7. Europe

  • 7.1. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Company
  • 7.2. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Type
  • 7.3. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Application
  • 7.4. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Countries
    • 7.4.1. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Countries
    • 7.4.2. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Countries
    • 7.4.3. Germany
    • 7.4.4. France
    • 7.4.5. UK
    • 7.4.6. Italy
    • 7.4.7. Russia

8. Asia Pacific

  • 8.1. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Company
  • 8.2. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Type
  • 8.3. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Application
  • 8.4. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Countries
    • 8.4.1. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Countries
    • 8.4.2. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Countries
    • 8.4.3. China
    • 8.4.4. Japan
    • 8.4.5. Korea
    • 8.4.6. India
    • 8.4.7. Australia
    • 8.4.8. Indonesia
    • 8.4.9. Malaysia
    • 8.4.10. Philippines
    • 8.4.11. Thailand
    • 8.4.12. Vietnam

9. Central & South America

  • 9.1. Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Company
  • 9.2. Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Type
  • 9.3. Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Application
  • 9.4. Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Countries
    • 9.4.1. Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Countries
    • 9.4.2. Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Countries
    • 9.4.3. Brazil

10. Middle East and Africa

  • 10.1. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Type
  • 10.2. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Application
  • 10.3. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Breakdown Data by Countries
    • 10.3.1. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales by Countries
    • 10.3.2. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Revenue by Countries
    • 10.3.3. GCC Countries
    • 10.3.4. Egypt
    • 10.3.5. South Africa

11. Company Profiles

  • 11.1. AstraZeneca
    • 11.1.1. AstraZeneca Company Details
    • 11.1.2. Company Description and Business Overview
    • 11.1.3. Sales, Revenue and Market Share of DPP IV Inhibitors (DPP-4 Inhibitors)
    • 11.1.4. DPP IV Inhibitors (DPP-4 Inhibitors) Product Introduction
    • 11.1.5. AstraZeneca Recent Development
  • 11.2. Boehringer
    • 11.2.1. Boehringer Company Details
    • 11.2.2. Company Description and Business Overview
    • 11.2.3. Sales, Revenue and Market Share of DPP IV Inhibitors (DPP-4 Inhibitors)
    • 11.2.4. DPP IV Inhibitors (DPP-4 Inhibitors) Product Introduction
    • 11.2.5. Boehringer Recent Development
  • 11.3. Eli Lilly
    • 11.3.1. Eli Lilly Company Details
    • 11.3.2. Company Description and Business Overview
    • 11.3.3. Sales, Revenue and Market Share of DPP IV Inhibitors (DPP-4 Inhibitors)
    • 11.3.4. DPP IV Inhibitors (DPP-4 Inhibitors) Product Introduction
    • 11.3.5. Eli Lilly Recent Development
  • 11.4. Merck
    • 11.4.1. Merck Company Details
    • 11.4.2. Company Description and Business Overview
    • 11.4.3. Sales, Revenue and Market Share of DPP IV Inhibitors (DPP-4 Inhibitors)
    • 11.4.4. DPP IV Inhibitors (DPP-4 Inhibitors) Product Introduction
    • 11.4.5. Merck Recent Development
  • 11.5. Mitsubishi Tanabe Pharma
    • 11.5.1. Mitsubishi Tanabe Pharma Company Details
    • 11.5.2. Company Description and Business Overview
    • 11.5.3. Sales, Revenue and Market Share of DPP IV Inhibitors (DPP-4 Inhibitors)
    • 11.5.4. DPP IV Inhibitors (DPP-4 Inhibitors) Product Introduction
    • 11.5.5. Mitsubishi Tanabe Pharma Recent Development
  • 11.6. Novartis
    • 11.6.1. Novartis Company Details
    • 11.6.2. Company Description and Business Overview
    • 11.6.3. Sales, Revenue and Market Share of DPP IV Inhibitors (DPP-4 Inhibitors)
    • 11.6.4. DPP IV Inhibitors (DPP-4 Inhibitors) Product Introduction
    • 11.6.5. Novartis Recent Development
  • 11.7. Takeda
    • 11.7.1. Takeda Company Details
    • 11.7.2. Company Description and Business Overview

12. Value Chain and Sales Channels Analysis

  • 12.1. Value Chain Analysis
  • 12.2. Sales Channels Analysis
    • 12.2.1. DPP IV Inhibitors (DPP-4 Inhibitors) Sales Channels
    • 12.2.2. DPP IV Inhibitors (DPP-4 Inhibitors) Distributors
  • 12.3. DPP IV Inhibitors (DPP-4 Inhibitors) Customers

13. Market Forecast

  • 13.1. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales and Revenue Forecast 2018-2025
  • 13.2. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Type
  • 13.3. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Application
  • 13.4. DPP IV Inhibitors (DPP-4 Inhibitors) Forecast by Regions
    • 13.4.1. Global DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Regions 2018-2025
    • 13.4.2. Global DPP IV Inhibitors (DPP-4 Inhibitors) Revenue Forecast by Regions 2018-2025
  • 13.5. North America Market Forecast
    • 13.5.1. North America DPP IV Inhibitors (DPP-4 Inhibitors) Forecast by Countries 2018-2025
    • 13.5.2. United States
    • 13.5.3. Canada
    • 13.5.4. Mexico
  • 13.6. Europe Market Forecast
    • 13.6.1. Europe DPP IV Inhibitors (DPP-4 Inhibitors) Forecast by Countries 2018-2025
    • 13.6.2. Germany
    • 13.6.3. France
    • 13.6.4. UK
    • 13.6.5. Italy
    • 13.6.6. Russia
  • 13.7. Asia Pacific Market Forecast
    • 13.7.1. Asia Pacific DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Countries 2018-2025
    • 13.7.2. China
    • 13.7.3. Japan
    • 13.7.4. Korea
    • 13.7.5. India
    • 13.7.6. Australia
    • 13.7.7. Indonesia
    • 13.7.8. Thailand
    • 13.7.9. Malaysia
    • 13.7.10. Philippines
    • 13.7.11. Vietnam
  • 13.8. Central & South America Market Forecast
    • 13.8.1. Central & South America DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Countries 2018-2025
    • 13.8.2. Brazil
  • 13.9. Middle East and Africa Market Forecast
    • 13.9.1. Middle East and Africa DPP IV Inhibitors (DPP-4 Inhibitors) Sales Forecast by Countries 2018-2025
    • 13.9.2. GCC Countries
    • 13.9.3. Egypt
    • 13.9.4. South Africa

14. Research Findings and Conclusion

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
      • 15.1.1.1. Research Programs/Design
      • 15.1.1.2. Market Size Estimation
      • 15.1.1.3. Market Breakdown and Data Triangulation
    • 15.1.2. Data Source
      • 15.1.2.1. Secondary Sources
      • 13.1.2.2. Primary Sources
  • 15.2. Author Details
  • 15.3. Disclaimer
Back to Top